Your session is about to expire
← Back to Search
Better Together for Aging Adults (B2G Trial)
N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
B2G Trial Summary
This trial will test whether a caregiver intervention can help older hospital patients be more physically active, as measured by daily step count, at 3 months.
Eligible Conditions
- Aging Adults
- Sedentary Lifestyle
- Caregiver
- Physical Activity
B2G Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Veterans Rand-12 Quality of Life
Secondary outcome measures
Action Plans behaviors
Brief Action Planning (BAP)
Coping Plans
+9 moreOther outcome measures
Brief Test of Adult Cognition by Telephone
Falls
Falls Efficacy Scale International (FES-I)
+2 moreB2G Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Better Together
2019
N/A
~30
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,467,016 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitments of participants still taking place for this experiment?
"The details available on clinicaltrials.gov indicate that this trial is not actively enrolling candidates at present. This research project was first posted to the registry on August 1st 2023 and last modified October 31st 2022, but there are still 220 other ongoing trials accepting patients."
Answered by AI
Share this study with friends
Copy Link
Messenger